![CVS Health Corporation](/common/images/company/NY_CVS.png)
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | 5.653 | 6.985 | -0.42 | 3.167 | 3.172 | 3.412 | 1.799 | 3.491 |
Return on Equity (%) | 14.363 | 17.77 | -1.272 | 10.812 | 10.739 | 10.904 | 5.657 | 11.279 |
Return on Invested Capital (%) | 10.326 | 12.848 | 16.873 | 11.166 | 12.694 | 12.146 | 6.334 | 13.694 |
Operating Margin (%) | 5.472 | 5.05 | 2.059 | 4.686 | 4.718 | 4.424 | 2.455 | 3.866 |
Net Profit Margin (%) | 2.995 | 3.584 | -0.315 | 2.584 | 2.675 | 2.708 | 1.287 | 2.332 |
Book Value Per Share | -13.949 | -14.062 | -43.448 | -37.146 | -31.077 | -24.689 | -24.225 | -33.954 |
Earnings Per Share | 4.969 | 6.473 | -0.469 | 5.06 | 5.449 | 5.96 | 3.179 | 6.458 |
Cash Per Share | 3.15 | 1.658 | 3.113 | 4.335 | 5.954 | 7.089 | 9.918 | 6.343 |
Working Capital Per Share | 4.409 | 0.568 | 0.946 | -2.289 | -4.282 | -5.876 | -2.996 | -8.77 |
Operating Profit Per Share | 29.299 | 30.539 | 26.255 | 38.006 | 40.518 | 39.564 | 40.545 | 45.506 |
EBIT Per Share | 8.072 | 8.082 | 1.064 | 6.862 | 7.407 | 7.851 | 4.312 | 8.647 |
EBITDA Per Share | 8.072 | 8.082 | 1.064 | 6.862 | 7.407 | 7.851 | 4.312 | 8.647 |
Free Cash Flow Per Share | 6.435 | 7.89 | 0.577 | 5.649 | 5.966 | 9.504 | 4.106 | 7.853 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 1.06B | 1.01B | 1.3B | 1.3B | 1.31B | 1.32B | 1.3B | N/A |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A | 1.3B | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | 4.067 | N/A | N/A | N/A | 2.596 |
Net Profit Margin (%) | N/A | N/A | N/A | 2.505 | N/A | N/A | N/A | 1.259 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 72.64B |
Price to Earnings Ratio | 8.86 |
Price to Sales Ratio | 0.21 |
Price to Cash Ratio | 9.02 |
Price to Book Ratio | 0.96 |
Dividend Yield | 412.27% |
Shares Outstanding | 1.26B |
Average Volume (1 week) | 6.34M |
Average Volume (1 Month) | 9.24M |
52 Week Change | -12.69% |
52 Week High | 83.25 |
52 Week Low | 52.7705 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.